Summary
The effect of metamphetamine, propylhexedrine and biperiden on reserpine rigidity in the rat was assessed in an electromyographical study. For comparison the anticonvulsant agent phenytoin was also included in the investigation. Tonic electromyographical activity during stretch of the calf muscles served as an indicator of rigidity. All drugs tested and their combinations depressed the rigidity elicited by an intravenous injection of a high dose of reserpine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arvidsson, J., I. Jurna, and G. Steg: Striatal and spinal lessions eliminating reserpine and physostigmine rigidity. Life Sci. 6, 2017–2020 (1967).
——, and G. Steg: Reciprocal effects on α- and γ-motoneurones of drugs influencing nomoaminergic and cholinergic transmission. Acta physiol. scand. 67, 398–404 (1966).
Bertler, Å.: Effect of reserpine on the storage of catecholamines in brain and other tissues. Acta physiol. scand. 51, 75–83 (1961).
Birkmayer, W., u. O. Hornykiewicz: Weitere experimentelle Untersuchungen über l-Dopa beim Parkinson-Syndrom und Reserpin-Parkinsonismus. Arch. Psychiat. Nervenkr. 206, 367–381 (1964).
Carlsson, A., M. Lindqvist, and T. Magnusson: 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature (Lond.) 180, 1200 (1957a).
Carlsson, A., E. Rosengren, Å. Bertler, and J. Nilsson: Effect of reserpine on the metabolism of catecholamines. In: Psychotropic Drugs. Garattini and Ghetti Ed. Amsterdam: Elsevier Publishing Comp. 1957(b).
Chen, G., and C. R. Ensor: Antagonism studies on reserpine and certain CNS depressants. Proc. Soc. exp. Biol. (N. Y.) 87, 602–608 (1954).
—— —— and B. Bohner: A facilitation action of reserpine on the central nervous system. Proc. Soc. exp. Biol. (N. Y.) 86, 507–510 (1954).
Ehringer, H., u. O. Hornykiewicz: Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wschr. 38, 1236–1239 (1960).
Esplin, D. W.: Effects of diphenylhydantoin on synaptic transmission in cat spinal cord and stellate ganglion. J. Pharmacol. exp. Ther. 120, 301–323 (1957).
Fellows, E. J., E. Macko, and R. McLean: Observations on several cyclohexyl- and phenylalkylamines. J. Pharmacol. exp. Ther. 100, 267–272 (1950).
Haas, H.: Über 3-Piperidino-1-phenyl-1-bicycloheptenyl-propanol-(1) (Akineton). Arch. int. Pharmacodyn. 128, 204–238 (1960).
——, u. W. Klavehn: Über 3-Piperidino-1-phenyl-1-bicycloheptenyl-propanol-(1) (Akineton). Naunyn-Schmiedebergs Arch. exper. Path. Pharmakol. 226, 18–35 (1955).
Holzbauer, A., and M. Vogt: Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J. Neurochem. 1, 8–11 (1956).
Jurna, I., and B. Regélhy: The antagonism between reserpine and some anti-parkinson drugs in electroseizure. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 259, 442–459 (1968).
Lands, A. M., and J. I. Grant: The vasopressor action and toxicity of cyclohexylethylamine derivatives. J. Pharmacol. exp. Ther. 106, 341–395 (1952).
——, and B. L. Dertinger: The pharmacologic activity of N-methyl-β-cyclohexyl-isopropylamine hydrochloride. J. Pharmacol. exp. Ther. 89, 382–385 (1947).
Marsh, D. F.: The comparative pharmacology of the cyclohexylamines. J. Pharmacol. exp. Ther. 93, 338–345 (1948).
——, and D. A. Herring: The comparative pressor activity of the optical isomers of cyclohexylisopropylamine and cyclohexylisopropylmethylamine. J. Pharmacol. exp. Ther. 97, 68–71 (1949).
P'an, S. Y., W. H. Funderburk, and K. F. Finger: Anticonvulsant effect of nialamide and diphenylhydantoin. Proc. Soc. exp. Biol. (N.Y.) 108, 680–683 (1961).
Roos, B.-E., and G. Steg: The effect of l-Dopa and 5-HTP on rigidity and tremor induced by reserpine, chlorpromazine and phenoxybenzamine. Life Sci. 3, 351–360 (1964).
Siegmund, O. H., W. L. Nash, and H. R. Granger: The vasopressor activity of some orally active sympathomimetic amines. J. Pharmacol. exp. Ther. 92, 207–213 (1948).
Steg, G.: Efferent muscle innevation and rigidity. Acta physiol. scand. 61, suppl. 225 (1964).
Umbach, W.: Klinische Erfahrungen mit Depot-Formen von Anti-Parkinson-Mitteln (Akineton und Kr 339 Knoll). Med. Welt 33, 1634–1637 (1963).
——, u. J. Woywode: Der Effekt eines Stoffes der Amphetamingruppe beim Parkinsonsyndrom mit überwiegender Akinesie. Med. Welt. 41, 2329–2336 (1965).
Author information
Authors and Affiliations
Additional information
Supported by a grant of the Deutsche Forschungsgemeinschaft.
Rights and permissions
About this article
Cite this article
Jurna, I. Depression by antiparkinson drugs of reserpine rigidity. Naunyn-Schmiedebergs Arch. Pharmak. u. Exp. Path. 260, 80–88 (1968). https://doi.org/10.1007/BF00545008
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00545008